![](/img/cover-not-exists.png)
[Lupus Foundation of America 11th European Lupus Meeting, Düsseldorf, Germany, 21â24 March 2018, Abstract presentations - ()] S7a â New therapeutic candidates - S7A:5â Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii)
Merril, JT, Morand, E, Wallace, DJ, Kao, A, Vazquez-Mateo, C, Chang, P, Fleuranceau-Morel, P, Isenberg, DADOI:
10.1136/lupus-2018-abstract.42
File:
PDF, 448 KB